The attendees can expect two highly interesting interviews with two well-known experts in the field of rheumatoid arthritis, namely Prof. Gerd Burmester and Prof. Mikkel Østergaard.

Prof. Burmester provides expert tips around MTX treatment of RA patients in the context of COVID-19 vaccinations and elaborates the effects of MTX hold on the vaccination response.

Prof. Østergaard elucidates the role of Methotrexate as an anchor drug in the treatment of rheumatoid arthritis, including the possibility of using it in a combination therapy. Furthermore, the advantages of subcutaneous Methotrexate over oral Methotrexate are highlighted.

This podcast has been funded by medac Gmbh, the market leader and innovator in scMTX therapy